Pan-immune-inflammation value as a novel prognostic biomarker for digestive system cancers: a meta-analysis.

ABSTRACT:

Background

Digestive system cancers pose a significant global health challenge with high incidence and mortality rates. Inflammation is a key factor in cancer progression, necessitating reliable prognostic indicators. The pan-immune-inflammation value (PIV), as a new biomarker of immune-inflammatory response, has emerged as a potential prognostic biomarker for cancers.

Methods

We performed a meta-analysis to evaluate the prognostic significance of PIV in digestive system cancers. Our search, up to June 2024, included 20 studies from 19 articles with 5037 patients. We extracted and analyzed data on PIV levels and assessed hazard ratios (HRs) for overall survival (OS), progression-free survival (PFS), disease-free survival (DFS), recurrence-free survival (RFS), and cancer-spec

SUBMITTER: Yu D 

PROVIDER: S-EPMC11577901 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature